Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Biopsy × Head & Neck × Clear all

Phase

Phase 2 20 Phase NA 15 Phase 1 9 Phase 1/2 4 Phase 2/3 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Lymphoid 9 Gastrointestinal 5 Sarcoma 4 Genitourinary 3 CNS 3 Breast 3 Plasma cell 2 Myeloid 2 Thoracic 1 Head & Neck 1 Gynecologic 1 Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 143 Radiotherapy 71 Fluorouracil 50 Radiotherapy, Intensity-Modulated 45 Docetaxel 39 Cetuximab 38 Gemcitabine 37 Carboplatin 31 pembrolizumab 25 Capecitabine 21 Drug Therapy 17 Paclitaxel 14 toripalimab 13 camrelizumab 10 Surgical Procedures, Operative 10 Nivolumab 10 Chemoradiotherapy 10 nimotuzumab 9 Radiation 8 Neoadjuvant Therapy 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Chemotherapy, Adjuvant 8 nedaplatin 7 Thyrotropin Alfa 7 Platinum 7 tislelizumab 6 spartalizumab 6 Standard of Care 6 Specimen Handling 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03519048 2026-03-30

SURVEILL'ORL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡